Ono Pharmaceutical : Core profit rose despite lower revenue, driven by royalties and overseas growth
Does Ono’s Expanding Oncology Pipeline and Qinlock Filing Reshape The Bull Case For Ono (TSE:4528)?
Ono Pharmaceutical (TSE:4528) Is Down 7.0% After Gastric Cancer Drug ONO-4578 Advances To Phase 3 – Has The Bull Case Changed?
Ono Pharma Announces Oral Presentation of New Data from the Phase 2 Clinical Study of ONO-4578 (EP4 antagonist) in Certain Gastric Cancers at the ASCO 2026 Annual Meeting
Ono Pharma Announces Poster Presentation of New Clinical Data from Phase 2 Study of ONO-2808 (S1P5 Receptor Agonist) in Multiple System Atrophy at the 7th World Parkinson Congress (WPC)
Analyst Estimates: Here's What Brokers Think Of Ono Pharmaceutical Co., Ltd. (TSE:4528) After Its Yearly Report